Elron Electronic Industries Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 15, 2021 at 01:26 am EDT
Share
Elron Electronic Industries Ltd. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue was USD 9.254 million compared to USD 440,000 a year ago. Net income was USD 881,000 compared to net loss of USD 3.619 million a year ago. Basic earnings per share from continuing operations was USD 0.02 compared to basic loss per share from continuing operations of USD 0.08 a year ago. For the half year, total revenue was USD 23.197 million compared to USD 215,000 a year ago. Net income was USD 8.809 million compared to net loss of USD 11.677 million a year ago. Basic earnings per share from continuing operations was USD 0.19 compared to basic loss per share from continuing operations of USD 0.27 a year ago. Diluted earnings per share from continuing operations was USD 0.18 compared to diluted loss per share from continuing operations of USD 0.27 a year ago.
Elron Electronic Industries Ltd. is an operational holding company that focuses on building and enhancing technology companies, mainly in the field of medical devices. Its group companies include companies at different stages of development and business maturation, operating in various technology fields, such as medical device and other fields. It is involved in the management of its group companies by means of membership and providing assistance to management. It operates in the Holdings and Corporate Operations segment. It is engaged in matters of policy guidance, strategic planning, marketing, selecting and manning senior management positions, determining the business plan, approving investments and budgets, development and operational guidance, assistance in creating strategic partnerships, and the overall ongoing monitoring of its group companies' performance. Its main group companies include BrainsGate Ltd, Pocared Diagnostics Ltd. and RDC Rafael Development Corporation Ltd.